Bone Health in Oncology: Closing Gaps, Reducing Costs, and Unlocking Biosimilar Value
Postmenopausal Osteoporosis: Clinical Burden, Treatment Barriers, and the Evolving Role of Denosumab Biosimilars
What is key to achieving a long-term sustainable biosimilars market?
Pfizer Global Biosimilars Commercial Lead, Roman Irsiegler, gives his thoughts on why a sustainable biosimilars market is critical for the healthcare industry, and what stakeholders can do to achieve it.
How can we achieve a long-term sustainable biosimilars market?
